Health Invest Partners Ab Mirum Pharmaceuticals, Inc. Transaction History
Health Invest Partners Ab
- $206 Million
- Q3 2024
A detailed history of Health Invest Partners Ab transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 138,321 shares of MIRM stock, worth $6.39 Million. This represents 2.62% of its overall portfolio holdings.
Number of Shares
138,321
Previous 75,200
83.94%
Holding current value
$6.39 Million
Previous $2.57 Million
109.8%
% of portfolio
2.62%
Previous 1.61%
Shares
3 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$304 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$207 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$159 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$150 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$142 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.7B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...